Prisma Health Cancer Institute — Greenville, South Carolina

Prisma Health Cancer Institute is a clinical research site located in Greenville, South Carolina, United States 29605.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Prisma Health Cancer Institute has participated in 34 clinical trials with 19 currently active.

Therapeutic areas: Leukemia, Myeloid, Acute, Metastatic Solid Tumor, Advanced Solid Tumor.

Sponsors: Delta-Fly Pharma, Inc., Coherus Oncology, Inc., Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Prisma Health Cancer Institute?

Prisma Health Cancer Institute has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Prisma Health Cancer Institute conducted?

Prisma Health Cancer Institute has 34 clinical trials on record, with 19 currently active. Their work covers Leukemia, Myeloid, Acute, Metastatic Solid Tumor, Advanced Solid Tumor.

Is Prisma Health Cancer Institute accredited by Crixeo Health?

Yes — Prisma Health Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Prisma Health Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.